The organotelluride catalyst LAB027 prevents colon cancer growth in the mice

Cell Death and Disease

Volumn 2, Issue 8, 2011, Pages

  Coriat, R ^a   Marut, W ^a   Leconte, M ^a   Ba, L B ^b   Vienne, A ^a   Chereau C ^a   Alexandre, J ^a   Weill, B ^a   Doering, M ^b   Jacob, C ^b   Nicco, C ^a   Batteux, F ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Colon cancer; Mice; Oxaliplatin; Reactive oxygen species; Tellurium

Indexed keywords

OXALIPLATIN; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT; CASPASE; GLUTATHIONE; HYDROGEN PEROXIDE; LAB 027; NAPHTHOQUINONE; ORGANOMETALLIC COMPOUND; PLATINUM COMPLEX; TELLURIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CANCER CELL; CANCER GROWTH; CATALYST; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; FEMALE; FIBROBLAST; GLUTATHIONE METABOLISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; CATALYSIS; CHEMISTRY; COLON TUMOR; DISEASE MODEL; DRUG EFFECT; METABOLISM; OXIDATION REDUCTION REACTION; TUMOR CELL LINE; XENOGRAFT;

MURINAE; MUS;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CATALYSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; MICE; NAPHTHOQUINONES; ORGANOMETALLIC COMPOUNDS; ORGANOPLATINUM COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; TELLURIUM; TRANSPLANTATION, HETEROLOGOUS;

EID: 80052322007     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.73     Document Type: Article

References (45)

1. Halliwell B, Gutteridge JM. Free Radicals in Biology and Medicine. Oxford University Press: UK, 2007.
2. Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 2002; 3: 420-425. (Pubitemid 34567428)
3. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 1995; 18: 775-794.
4. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 1990; 265: 659-665. (Pubitemid 20053867)
5. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB et al. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 1997; 272: 217-221. (Pubitemid 27021147)
6. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science (New York, NY) 1995; 270: 296-299.
7. Jackson AL, Loeb LA. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer. Mutat Res 2001; 477: 7-21. (Pubitemid 32480184)
8. Gupta A, Rosenberger SF, Bowden GT. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. Carcinogenesis 1999; 20: 2063-2073. (Pubitemid 29535306)
9. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005; 65: 948-956. (Pubitemid 40216456)
10. Mates JM, Segura JA, Alonso FJ, Marquez J. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis. Arch Toxicol 2008; 82: 273-299.
11. Oberley TD, Oberley LW. Antioxidant enzyme levels in cancer. Histol Histopathol 1997; 12: 525-535. (Pubitemid 27240324)
12. Benhar M, Dalyot I, Engelberg D, Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogenactivated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 2001; 21: 6913-6926. (Pubitemid 32911252)
13. Jabs T. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals. Biochem Pharmacol 1999; 57: 231-245. (Pubitemid 29056201)
14. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 2001; 7: 1111-1117. (Pubitemid 33010018)
15. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999; 94: 2102-2111. (Pubitemid 29430427)
16. Alexandre J, Nicco C, Chereau C, Laurent A, Weill B, Goldwasser F et al. Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 2006; 98: 236-244. (Pubitemid 43264707)
17. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I et al. p53-induced upregulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 2004; 64: 2350-2356. (Pubitemid 38523887)
18. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev 2009; 8: 579-591.
19. Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC. Crossresistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res 1993; 53: 5225-5232. (Pubitemid 23333392)
20. Skapek SX, Colvin OM, Griffith OW, Elion GB, Bigner DD, Friedman HS. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice. Cancer Res 1988; 48: 2764-2767.
21. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D et al. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res 2003; 63: 1297-1303. (Pubitemid 36348708)
22. Zhang Y, Zhao W, Zhang HJ, Domann FE, Oberley LW. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 2002; 62: 1205-1212. (Pubitemid 34160310)
23. Hileman EO, Liu J, Albitar M, Keating MJ, Huang P. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol 2004; 53: 209-219. (Pubitemid 38293718)
24. Mecklenburg S, Shaaban S, Ba LA, Burkholz T, Schneider T, Diesel B et al. Exploring synthetic avenues for the effective synthesis of selenium- and tellurium-containing multifunctional redox agents. Org Biomol Chem 2009; 7: 4753-4762.
25. Shabaan S, Ba LA, Abbas M, Burkholz T, Denkert A, Gohr A et al. Multicomponent reactions for the synthesis of multifunctional agents with activity against cancer cells. Chem Commun (Camb, England) 2009; 40: 4702-4704.
26. Joza N, Kroemer G, Penninger JM. Genetic analysis of the mammalian cell death machinery. Trends Genet 2002; 18: 142-149. (Pubitemid 34164640)
27. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 2007; 47: 143-183.
28. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 2007; 26: 1749-1760. (Pubitemid 46624042)
29. Azad MB, Chen Y, Gibson SB. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid Redox Signal 2009; 11: 777-790.
30. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971; 44: 276-287.
31. Diaz-Rubio E, Sastre J, Zaniboni A, Labianca R, Cortes-Funes H, de Braud F et al. Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric study. Ann Oncol 1998; 9: 105-108. (Pubitemid 28125772)
32. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A 1992; 89: 3070-3074.
33. Bailey HH, Mulcahy RT, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB et al. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione. J Clin Oncol 1994; 12: 194-205. (Pubitemid 24020640)
34. Bailey HH, Ripple G, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C et al. Phase I study of continuous-infusion L-SR-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst 1997; 89: 1789-1796. (Pubitemid 27516233)
35. Hayun M, Naor Y, Weil M, Albeck M, Peled A, Don J et al. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway. Biochem Pharmacol 2006; 72: 1423-1431. (Pubitemid 44666735)
36. Sredni B, Caspi RR, Klein A, Kalechman Y, Danziger Y, Ben Ya'akov M et al. A new immunomodulating compound (AS-101) with potential therapeutic application. Nature 1987; 330: 173-176. (Pubitemid 17158547)
37. Sredni B, Tichler T, Shani A, Catane R, Kaufman B, Strassmann G et al. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101. J Natl Cancer Inst 1996; 88: 1276-1284. (Pubitemid 26301615)
38. Okun E, Dikshtein Y, Carmely A, Saida H, Frei G, Sela BA et al. The organotellurium compound ammonium trichloro(dioxoethylene-o,o0)tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice. FEBS J 2007; 274: 3159-3170. (Pubitemid 46849091)
39. Frei GM, Kremer M, Hanschmann KM, Krause S, Albeck M, Sredni B et al. Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound AS101. Br J Dermatol 2008; 158: 578-586. (Pubitemid 351239194)
40. Sredni B, Xu RH, Albeck M, Gafter U, Gal R, Shani A et al. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. Int J Cancer 1996; 65: 97-103.
41. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
42. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985; 113: 484-490. (Pubitemid 16195819)
43. Baker MA, Cerniglia GJ, Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 1990; 190: 360-365. (Pubitemid 20371981)
44. Rice GC, Bump EA, Shrieve DC, Lee W, Kovacs M. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res 1986; 46: 6105-6110. (Pubitemid 17221738)
45. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res 2003; 63: 2103-2108. (Pubitemid 36538613)